{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:16:45Z","timestamp":1789402605960,"version":"build-2803163510"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:00:00Z","timestamp":1629417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Coronavirus disease 2019 (COVID-19) broke out and then became a global epidemic at the end of 2019. With the increasing number of deaths, early identification of disease severity and interpretation of pathogenesis are very important. Aiming to identify biomarkers for disease severity and progression of COVID-19, 75 COVID-19 patients, 34 healthy controls and 23 patients with pandemic influenza A(H1N1) were recruited in this study. Using liquid chip technology, 48 cytokines and chemokines were examined, among which 33 were significantly elevated in COVID-19 patients compared with healthy controls. HGF and IL-1\u03b2 were strongly associated with APACHE II score in the first week after disease onset. IP-10, HGF and IL-10 were correlated positively with virus titers. Cytokines were significantly correlated with creatinine, troponin I, international normalized ratio and procalcitonin within two weeks after disease onset. Univariate analyses were carried out, and 6 cytokines including G-CSF, HGF, IL-10, IL-18, M-CSF and SCGF-\u03b2 were found to be associated with the severity of COVID-19. 11 kinds of cytokines could predict the severity of COVID-19, among which IP-10 and M-CSF were excellent predictors for disease severity. In conclusion, the levels of cytokines in COVID-19 were significantly correlated with the severity of the disease in the early stage, and serum cytokines could be used as warning indicators of the severity and progression of COVID-19. Early stratification of disease and intervention to reduce hypercytokinaemia may improve the prognosis of COVID-19 patients.<\/jats:p>","DOI":"10.3389\/fimmu.2021.681516","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T03:24:54Z","timestamp":1629429894000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":81,"title":["Cytokine Signature Associated With Disease Severity in COVID-19"],"prefix":"10.3389","volume":"12","author":[{"given":"Jing","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufa","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hainv","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongkang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenjie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafeng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqing","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifang","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,20]]},"reference":[{"key":"B1","article-title":"A Predictive Nomogram for Predicting Improved Clinical Outcome Probability in Patients With COVID-19 in Zhejiang Province, China","volume-title":"Engineering (Beijing)","author":"Zhu","year":"2020"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus From Patients With Pneumonia in China, 2019","volume":"382","author":"Xie","year":"2020","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5582\/bst.2020.01020","article-title":"Drug Treatment Options for the 2019-New Coronavirus (2019-nCoV)","volume":"14","author":"Hongzhou","year":"2020","journal-title":"Biosci Trends"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.09.031","article-title":"COVID-19: Discovery, Diagnostics and Drug Development","volume":"74","author":"Asselah","year":"2021","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider Cytokine Storm Syndromes and Immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwaa037","article-title":"Elevated Plasma Levels of Selective Cytokines in COVID-19 Patients Reflect Viral Load and Lung Injury","volume":"7","author":"Jiang","year":"2020","journal-title":"Natl Sci Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa363","article-title":"Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China","volume":"222","author":"Chi","year":"2020","journal-title":"J Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical Features of Patients Infected With 2019 Novel Coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2020.06.009","article-title":"Coronavirus Disease 2019 (COVID-19): Cytokine Storms, Hyper-Inflammatory Phenotypes, and Acute Respiratory Distress Syndrome","volume":"7","author":"Lin","year":"2020","journal-title":"Genes Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological Findings of COVID-19 Associated With Acute Respiratory Distress Syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s12024-020-00310-8","article-title":"Autopsy Findings in COVID-19-Related Deaths: A Literature Review","volume":"17","author":"Maiese","year":"2020","journal-title":"Forensic Sci Med Pathol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2020.0317","article-title":"Immune Characteristics of Patients With Coronavirus Disease 2019 (COVID-19)","volume":"11","author":"Dong","year":"2020","journal-title":"Aging Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"15838","DOI":"10.1038\/s41598-020-72718-9","article-title":"Immune Dysfunction Following COVID-19, Especially in Severe Patients","volume":"10","author":"Song","year":"2020","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa709","article-title":"Alterations of the Gut Microbiota in Patients With COVID-19 or H1N1 Influenza","volume":"71","author":"Gu","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"m606","DOI":"10.1136\/bmj.m606","article-title":"Clinical Findings in a Group of Patients Infected With the 2019 Novel Coronavirus (SARS-Cov-2) Outside of Wuhan, China: Retrospective Case Series","volume":"368","author":"Xu","year":"2020","journal-title":"BMJ"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: A Severity of Disease Classification System","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.593595","article-title":"Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza a(H1N1)","volume":"12","author":"Choreno-Parra","year":"2021","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.586073","article-title":"The Artificial-Liver Blood-Purification System Can Effectively Improve Hypercytokinemia for COVID-19","volume":"11","author":"Guo","year":"2020","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23478","article-title":"Evaluation of the Neutrophil-To-Lymphocyte Ratio, Monocyte-To-Lymphocyte Ratio, and Red Cell Distribution Width for the Prediction of Prognosis of Patients With Hepatitis B Virus-Related Decompensated Cirrhosis","volume":"34","author":"Li","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4107219","article-title":"Mean Platelet Volume\/Lymphocyte Ratio as a Prognostic Indicator for HBV-Related Decompensated Cirrhosis","volume":"2020","author":"Wu","year":"2020","journal-title":"Gastroenterol Res Pract"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2006.00942.x","article-title":"Temporal Changes in Cytokine\/Chemokine Profiles and Pulmonary Involvement in Severe Acute Respiratory Syndrome","volume":"11","author":"Chien","year":"2006","journal-title":"Respirology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jaci.2020.04.027","article-title":"Plasma IP-10 and MCP-3 Levels Are Highly Associated With Disease Severity and Predict the Progression of COVID-19","volume":"146","author":"Yang","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200407-857OC","article-title":"Characterization of Cytokine\/Chemokine Profiles of Severe Acute Respiratory Syndrome","volume":"171","author":"Jiang","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cyto.2018.01.025","article-title":"MERS-Cov Infection in Humans Is Associated With a Pro-Inflammatory Th1 and Th17 Cytokine Profile","volume":"104","author":"Mahallawi","year":"2018","journal-title":"Cytokine"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155500","article-title":"Serum IP-10 and IL-7 Levels Are Associated With Disease Severity of Coronavirus Disease 2019","volume":"142","author":"Wang","year":"2021","journal-title":"Cytokine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1186\/s13054-020-03328-0","article-title":"CXCL10 Could Drive Longer Duration of Mechanical Ventilation During COVID-19 ARDS","volume":"24","author":"Blot","year":"2020","journal-title":"Crit Care"},{"key":"B27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s10020-020-00230-x","article-title":"IP-10 and MCP-1 as Biomarkers Associated With Disease Severity of COVID-19","volume":"26","author":"Chen","year":"2020","journal-title":"Mol Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.08.031","article-title":"Characterization of the Cytokine Storm Reflects Hyperinflammatory Endothelial Dysfunction in COVID-19","volume":"147","author":"Sims","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/srep10942","article-title":"The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients Can Predict Fatal Outcomes","volume":"5","author":"Guo","year":"2015","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2017.03.003","article-title":"Serum IFN-Gamma-Induced Protein 10 (IP-10) as a Biomarker for Severity of Acute Respiratory Infection in Healthy Adults","volume":"90","author":"Hayney","year":"2017","journal-title":"J Clin Virol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.04.006","article-title":"Risk Factors for Severity and Mortality in Adult COVID-19 Inpatients in Wuhan","volume":"146","author":"Li","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.200160","article-title":"Cytokine Storm and COVID-19: A Chronicle of Pro-Inflammatory Cytokines","volume":"10","author":"Fara","year":"2020","journal-title":"Open Biol"},{"key":"B33","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150107","article-title":"IL-13 Is a Driver of COVID-19 Severity","volume-title":"medRxiv","author":"Donlan","year":"2021"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.131232","article-title":"Interleukin-13 Disrupts Type 2 Pneumocyte Stem Cell Activity","volume":"5","author":"Glisinski","year":"2020","journal-title":"JCI Insight"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16749","article-title":"COVID19 Coagulopathy in Caucasian Patients","volume":"189","author":"Fogarty","year":"2020","journal-title":"Br J Haematol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1365-2141.2001.03061.x","article-title":"Interleukin 6 and Haemostasis","volume":"115","author":"Kerr","year":"2001","journal-title":"Br J Haematol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00146808","article-title":"Interleukin-8 Activates Coagulation and Correlates With Survival After Talc Pleurodesis","volume":"35","author":"Montes-Worboys","year":"2010","journal-title":"Eur Respir J"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.04.003","article-title":"Interleukin-18 Serum Levels in Sepsis: Correlation With Disease Severity and Inflammatory Markers","volume":"120","author":"Mierzchala-Pasierb","year":"2019","journal-title":"Cytokine"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155302","article-title":"Prognostic Value of Interleukin-18 and Its Association With Other Inflammatory Markers and Disease Severity in COVID-19","volume":"137","author":"Satis","year":"2020","journal-title":"Cytokine"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab Treatment in COVID-19: A Single Center Experience","volume":"92","author":"Luo","year":"2020","journal-title":"J Med Virol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2005615117","article-title":"Effective Treatment of Severe COVID-19 Patients With Tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.09.018","article-title":"IL-6 Serum Levels Predict Severity and Response to Tocilizumab in COVID-19: An Observational Study","volume":"147","author":"Galvan-Roman","year":"2020","journal-title":"J Allergy Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.681516\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T13:34:36Z","timestamp":1673098476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.681516\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,20]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2021.681516"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.681516","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,20]]},"article-number":"681516"}}